Na Li

5PUBLICATIONS
10CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthBiologically active moleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3.

|Sep 14, 2023
KIAA1429/VIRMA promotes breast cancer progression by m6 A-dependent cytosolic HAS2 stabilization.

Na Li, Zhouting Zhu, Yufei Deng

|Mar 27, 2023
Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy.

Zhouting Zhu, Rachel Tang, Sarah Huff

|Feb 12, 2022
Regulation of antiviral innate immunity by chemical modification of viral RNA.

Na Li, Tariq M Rana

|Aug 05, 2020
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.

Na Li, Yuqi Kang, Lingling Wang

Pageof 1

Frequent Collaborators

4 joint publications

Tariq M Rana

3 joint publications

Zhouting Zhu

1 joint publications

Rachel Tang

1 joint publications

Sarah Huff